European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1245-1249 , December 2009

Factors predicting the sentinel node metastases in T1 breast cancer tumor:An analysis of 1416 cases

  • J. Capdet

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • Corresponding Author InformationCorresponding author at: University Toulouse III Paul Sabatier, Toulouse F-31000, France. Tel.: +33 5 61 42 41 48.
    • ,
  • P. Martel

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • H. Charitansky

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • Y.K.T. Lim

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • G. Ferron

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • L. Battle

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • A. Landier

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France
    • ,
  • E. Mery

      Affiliations

    • Institut Claudius Regaud, Department of Pathology, Toulouse F-31052, France
    • ,
  • S. Zerdoub

      Affiliations

    • Institut Claudius Regaud, Department of Nuclear Medicine, Toulouse F-31052, France
    • ,
  • H. Roche

      Affiliations

    • Institut Claudius Regaud, Department of Medical Oncology, Toulouse F-31052, France
    • ,
  • D. Querleu

      Affiliations

    • Institut Claudius Regaud, Department of Surgical Oncology, 20-24 rue du pont saint pierre Toulouse, Toulouse F-31052, France

,Accepted 2 June 2009.

References 

  1. Fisher B, Redmond C, Fisher ER. The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology – an overview of findings. Cancer. 1980 Aug 15;46(4 Suppl.):1009–1025
  2. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst. 2006 May 3;98(9):599–609
  3. Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007 Mar;245(3):452–461
  4. Helms G, Kühn T, Moser L, et al. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial. Eur J Surg Oncol. 2008 Oct 4;
  5. Chagpar AB, Martin RC, Scoggins CR, et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery. 2005 Jul;138(1):56–63
  6. Martel P, Capdet J, Méry E, et al. Critical study of our initial experience of 993 sentinel node biopsies for breast surgery. Bull Cancer. 2008 Jul–Aug;95(7):763–772
  7. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008 Nov 10;26(32):5213–5219
  8. Yip CH, Taib NA, Tan GH, et al. Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?. World J Surg. 2009 Jan;33(1):54–57
  9. Chua B, Ung O, Taylor R, et al. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001 Dec;71(12):701
  10. Barkley CR, Ligibel JA, Wong JS, et al. Mucinous breast carcinoma: a large contemporary series. Am J Surg. 2008 Oct;196(4):549–551
  11. Ozmen V, Karanlik H, Cabioglu N, et al. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat. 2006 Jan;95(1):1–6
  12. González-Vela MC, Garijo MF, Fernández FA, et al. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors. Pathol Res Pract. 1999;195(9):611–618
  13. Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005 Aug;31(6):568–576[Epub 2005 Apr 15. Review]
  14. Krag DN, Julian TB, Harlow SP, et al. NSABP-32: phase III, randomized trial comparing axillary resection with sentinel lymph node dissection: a description of the trial. Ann Surg Oncol. 2004 Mar;11(3 Suppl.):208S–210S
  15. Nouh MA, Ismail H, El-Din NH, et al. Lymph node metastasis in breast carcinoma: clinicopathological correlations in 3747 patients. J Egypt Natl Cancer Inst. 2004 Mar;16(1):50–56
  16. Cutuli B, Velten M, Martin C. Assessment of axillary lymph node involvement in small breast cancer: analysis of 893 cases. Clin Breast Cancer. 2001 Apr;2(1):59–65[discussion 66]
  17. Bass SS, Lyman GH, McCann CR, et al. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers <1centimeter (T1A-T1B). Am Surg. 1999 Sep;65(9):857–861
  18. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999 Nov;230(5):692–696
  19. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast cancers. Cancer. 1997 May 15;79(10):1918–1922
  20. Bevilacqua J, Cody H, MacDonald KA, et al. A prospective validated model for predicting axillary node metastases based on 2000 sentinel node procedures: the role of tumour location. Eur J Surg Oncol. 2002 Aug;28(5):490–500
  21. Orr RK. The impact of of prophylactic axillary node dissection on breast cancer survival – a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109–116
  22. Cinieri S, Orlando L, Fedele P, et al. Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference. Ann Oncol. 2007 Jun;18(Suppl. 6):vi63–vi65[review]
  23. Sanghani M, Balk EM, Cady B. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients. Cancer. 6 feb 2009;
  24. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005 Jul;242(1):1–6[discussion 7–9]
  25. Rudenstam CM, Zahrieh D, Forbes JF, et al. International Breast Cancer Study Group Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006 Jan 20;24(3):337–344[Epub 2005 Dec 12]

PII: S0748-7983(09)00179-6

doi: 10.1016/j.ejso.2009.06.002

European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1245-1249 , December 2009

Article Tools